Best Practices to scale global hybrid decentralized studies - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Best Practices to scale global hybrid decentralized studies

08 Nov 2021 (Last Updated November 23rd, 2021 16:49)

Sponsored by THREAD Sponsored by Visit Company

As the industry continues to shift to decentralized clinical trial (DCT) approaches, sponsors and CROs must now focus on how to make this change globally. This session will outline best practices learned over the past years in conducting global DCTs that should be considered to scale globally across complex regulatory landscapes.

Watch the video to learn:

  • How to identify and plan the initial studies for DCT approaches to scale
  • Understand how to evaluate country-specific regulatory requirements and feature specific limitations
  • Assess DCT providers for optimal capabilities related to integrations, technical helpdesk, device provisioning and multi-lingual support availability

Speaker

John Reites, CEO, THREAD


Free Webinar

THREAD: Best Practices to Scale Global Hybrid Decentralized Studies

Download and watch the webinar